Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • dinepat203 dinepat203 Feb 1, 2013 9:19 AM Flag

    BLOCKED GLAXO / EVERYONE ON USE OF PURE EPA...AMARIN ON TRACK FOR NCE

    Amarin's U.S. Patent Application Serial Number 13/272,520 titled "Compositions and Methods for Lowering Triglycerides." This application includes claims intended to protect the proposed Vascepa® (icosapent ethyl) indication based on Amarin's Phase 3 ANCHOR clinical trial results.

    The claims in this allowed application cover a method of use relating to Vascepa's ANCHOR indication. Specifically, the allowed independent claims covers use of about 4 grams per day of highly pure icosapent ethyl, or EPA, including Vascepa, to lower triglycerides and LDL-C.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 2500 tons per year or 2.27 million Kg / 5,000,000 lbs (2500 tons from BASF web site)

      2,270,000,000 grams divided by 4 gram dose = 567,500,000 4 gram doses per year

      Enough to supply 1,554,794 pts per year with 4 grams.

      Anchor indication is about 44,000,000 patients

      3.5% penetration of Anchor's 44,000,000

      3.9% penetration of Marine indication

      $6 per day for a 4 gram dose = $3.4 Billion
      ----------------
      Amarin will still need more API.

      $50+ stock folks...

      Sentiment: Strong Buy

 
AMRN
3.07-0.11(-3.46%)Aug 24 4:00 PMEDT